<DOC>
	<DOCNO>NCT00441558</DOCNO>
	<brief_summary>To determine long-term treatment Flibanserin safe monitor effectiveness Flibanserin Women HSDD already complete previous study ( 511.70/71/.74/.75/.105 ) Flibanserin .</brief_summary>
	<brief_title>A One-year Safety Study Flibanserin Treat Pre-Menopausal Women With Hypoactive Sexual Desire Disorder ( HSDD ) .</brief_title>
	<detailed_description />
	<mesh_term>Sexual Dysfunctions , Psychological</mesh_term>
	<criteria>1 . Women primary diagnosis HSDD complete previous study Flibanserin . 2 . Patients must use medically acceptable method contraception least 2 month start study continue use method duration study . 3 . Patients must reliable , compliant , agree cooperate study evaluation . 4 . Patients must able willing give meaningful , write informed consent prior start study willing discus sexual functioning study staff . 1 . A history Major Depressive Disorder within 6 month prior start study , current suicidal thought , history suicide attempt . 2 . Participation another clinical trial within 1 month prior start study , except Flibanserin . 3 . Patients pelvic inflammatory disease , urinary tract infection , vaginal infection/vaginitis , cervicitis , interstitial cystitis , vulvodynia , significant vaginal atrophy . 4 . Patients pregnant pregnant within 1 month prior study start . 5 . Patients experience major life stress ( include loss income , death family member , major illness , etc . ) relationship trouble could interfere sexual activity , except distress HSDD . 6 . Clinically significant ECG lab abnormality study start . 7 . Patients take prohibited medication exclude previous trial contribute sexual dysfunction safetyrelated interaction .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>